Joseph Stephenson

860 total citations
17 papers, 705 citations indexed

About

Joseph Stephenson is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Joseph Stephenson has authored 17 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Joseph Stephenson's work include Cancer therapeutics and mechanisms (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Respiratory viral infections research (2 papers). Joseph Stephenson is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Respiratory viral infections research (2 papers). Joseph Stephenson collaborates with scholars based in United States and Canada. Joseph Stephenson's co-authors include Peter J. Ferguson, Bingsen Zhou, M. H. FISHER, Yung-Chi Cheng, Eric K. Rowinsky, Charles M. Rudin, Neil Senzer, Paul L. Hallenbeck, Kevin D. Burroughs and Christine L. Hann and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Joseph Stephenson

17 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Stephenson United States 8 386 320 130 94 92 17 705
Stefan Jenewein Germany 10 493 1.3× 380 1.2× 115 0.9× 54 0.6× 132 1.4× 14 871
Siddhartha Dutta Gupta India 15 155 0.4× 431 1.3× 100 0.8× 100 1.1× 41 0.4× 24 811
Michael Kriegler United States 7 415 1.1× 492 1.5× 48 0.4× 27 0.3× 153 1.7× 7 942
R. N. Taub United States 15 206 0.5× 235 0.7× 53 0.4× 168 1.8× 92 1.0× 35 819
Ian Clarke United Kingdom 12 418 1.1× 588 1.8× 68 0.5× 73 0.8× 43 0.5× 18 1.0k
Roberto Camerini Italy 17 214 0.6× 351 1.1× 53 0.4× 59 0.6× 64 0.7× 27 844
Ann Mander United Kingdom 15 230 0.6× 320 1.0× 44 0.3× 246 2.6× 68 0.7× 24 966
Bing‐Ching Ho Taiwan 17 352 0.9× 627 2.0× 39 0.3× 409 4.4× 45 0.5× 29 1.2k
Emanuele Marra Italy 18 242 0.6× 365 1.1× 114 0.9× 116 1.2× 42 0.5× 36 761
Maria Massucci Italy 11 228 0.6× 255 0.8× 22 0.2× 181 1.9× 38 0.4× 17 722

Countries citing papers authored by Joseph Stephenson

Since Specialization
Citations

This map shows the geographic impact of Joseph Stephenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Stephenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Stephenson more than expected).

Fields of papers citing papers by Joseph Stephenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Stephenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Stephenson. The network helps show where Joseph Stephenson may publish in the future.

Co-authorship network of co-authors of Joseph Stephenson

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Stephenson. A scholar is included among the top collaborators of Joseph Stephenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Stephenson. Joseph Stephenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kocher, Madison, Joseph Stephenson, Dhiraj Baruah, et al.. (2022). Tumor burden of lung metastases at initial staging in breast cancer patients detected by artificial intelligence as a prognostic tool for precision medicine. Heliyon. 8(2). e08962–e08962. 7 indexed citations
2.
Kocher, Madison, Joseph Stephenson, Pooyan Sahbaee, et al.. (2021). Automated detection of lung nodules and coronary artery calcium using artificial intelligence on low-dose CT scans for lung cancer screening: accuracy and prognostic value. BMC Medicine. 19(1). 55–55. 95 indexed citations
3.
Petrylak, Daniel P., Philip W. Kantoff, Anthony Mega, et al.. (2012). 244 Prostate Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC): a Phase 1 Trial in Castration-Resistant Metastatic Prostate Cancer (mCRPC). European Journal of Cancer. 48. 75–75. 4 indexed citations
4.
Rudin, Charles M., John T. Poirier, Neil Senzer, et al.. (2011). Phase I Clinical Study of Seneca Valley Virus (SVV-001),a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features. Clinical Cancer Research. 17(4). 888–895. 128 indexed citations
5.
Tebbutt, N. C., Lara Lipton, Ralph V. Boccia, et al.. (2011). The effect of motesanib treatment on the gallbladder: A randomized phase Ib study in patients (pts) with advanced solid tumors.. Journal of Clinical Oncology. 29(15_suppl). e13555–e13555. 3 indexed citations
6.
Borad, Mitesh J., Darren Sigal, Hope E. Uronis, et al.. (2011). Randomized phase II study of the efficacy and safety of gemcitabine plus TH-302 versus gemcitabine alone in previously untreated patients with advanced pancreatic cancer.. Journal of Clinical Oncology. 29(15_suppl). TPS176–TPS176. 5 indexed citations
7.
Rudin, Charles M., Neil Senzer, Joseph Stephenson, et al.. (2009). Phase I study of intravenous Seneca Valley virus (NTX-010), a replication competent oncolytic virus, in patients with neuroendocrine (NE) cancers. Journal of Clinical Oncology. 27(15_suppl). 4629–4629. 7 indexed citations
8.
Hamid, Omid, Wallace Akerley, Joseph Stephenson, et al.. (2009). Abstract C230: MPC-6827 is safely combined with temozolomide for the treatment of patients with metastatic melanoma. Molecular Cancer Therapeutics. 8(12_Supplement). C230–C230. 1 indexed citations
9.
Laskin, Janessa, Hao Dong, Christina Canil, et al.. (2007). A phase I/II study of OGX-011 and a gemcitabine (GEM)/platinum regimen as first-line therapy in 85 patients with advanced non-small cell lung cancer. Journal of Clinical Oncology. 25(18_suppl). 7596–7596. 7 indexed citations
10.
Raza, Azra, Joseph G. Jurcic, Gail J. Roboz, et al.. (2007). Complete Remissions Observed in Acute Myeloid Leukemia Following Prolonged Exposure to SGN-33 (lintuzumab), a Humanized Monoclonal Antibody Targeting CD33.. Blood. 110(11). 159–159. 7 indexed citations
11.
Bono, Johann S. de, Sun Young Rha, Joseph Stephenson, et al.. (2004). Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity. Annals of Oncology. 15(12). 1825–1833. 58 indexed citations
12.
Bono, Johann S. de, Joseph Stephenson, Sharyn D. Baker, et al.. (2002). Troxacitabine, an l-Stereoisomeric Nucleoside Analog, on a Five-Times-Daily Schedule: A Phase I and Pharmacokinetic Study in Patients With Advanced Solid Malignancies. Journal of Clinical Oncology. 20(1). 96–109. 16 indexed citations
13.
Hidalgo, Manuel, Cheryl Aylesworth, Lisa A. Hammond, et al.. (2001). Phase I and Pharmacokinetic Study of BMS-184476, a Taxane With Greater Potency and Solubility Than Paclitaxel. Journal of Clinical Oncology. 19(9). 2493–2503. 33 indexed citations
14.
Stephenson, Joseph, et al.. (2000). The Contribution of National Vocational Qualifications (NVQs) to the Learning Milieu of the Work-Place. 4 indexed citations
15.
Drengler, Ronald, John G. Kuhn, Larry J. Schaaf, et al.. (1999). Phase I and Pharmacokinetic Trial of Oral Irinotecan Administered Daily for 5 Days Every 3 Weeks in Patients With Solid Tumors. Journal of Clinical Oncology. 17(2). 685–685. 85 indexed citations
16.
Rowinsky, Eric K., Lee Smith, Pravin Chaturvedi, et al.. (1998). Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP.. Journal of Clinical Oncology. 16(9). 2964–2976. 114 indexed citations
17.
Ferguson, Peter J., et al.. (1988). Combined modalities of resistance in etoposide-resistant human KB cell lines.. PubMed. 48(21). 5956–64. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Jenewein Breakdown of academic impact, for papers by Siddhartha Dutta Gupta Breakdown of academic impact, for papers by Michael Kriegler Breakdown of academic impact, for papers by R. N. Taub Breakdown of academic impact, for papers by Ian Clarke Breakdown of academic impact, for papers by Roberto Camerini Breakdown of academic impact, for papers by Ann Mander Breakdown of academic impact, for papers by Bing‐Ching Ho Breakdown of academic impact, for papers by Emanuele Marra Breakdown of academic impact, for papers by Maria Massucci
Rankless by CCL
2026